Regeneron and Sanofi bust into new I-O market with FDA nod for Libtayo in basal cell carcinoma February 10, 2021 Auto Bot News 0 Regeneron and Sanofi bust into new I-O market with FDA nod for Libtayo in basal cell carcinoma arlene.weintraub Wed, 02/10/2021 – 09:55
